Arvaya Healthcare to Acquire SIGPL for ₹15.49 Cr via Share Swap

Arvaya Healthcare Limited's Board of Directors has approved the acquisition of 100% equity shares of Sushodha Institute of Gastroenterology Private Limited (SIGPL) for a total consideration of ₹15,48,74,160. The acquisition will be discharged through the issuance of up to 38,71,854 equity shares of Arvaya Healthcare at ₹40 per share. This transaction is subject to shareholder and regulatory approvals. Additionally, the board approved a preferential issue of equity shares to SIGPL shareholders as consideration for the acquisition and formed a Rights Issue Committee to oversee a proposed Rights Issue of up to ₹210 Crores.